Johnson & Johnson (JNJ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Johnson & Johnson | JNJ | Healthcare | Drug Manufacturers - General | 97 | 8.6% |
| Current Price ( 1/27 4:00PM EST) | $168.23 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 96,041.0 | |||
| Sales Growth Forecast | 4.4% | |||
| Net Profit Margin | 28.2% | |||
| Projected Shares Outstanding | 2,508.00 | |||
| EPS - Five year Forecast | $13.37 | |||
| Average P/E Ratio | 17.0 | |||
| Projected Average Price | $227.25 | |||
| Price Appreciation (Annualized) | 6.2% | |||
| Annual Dividend Yield | 2.4% | |||
| Projected Annual Return | 8.6% | |||
| Quality | ||||
| Financial Strength | 100 | 25.0 | ||
| EPS Stability | 92 | 23.0 | ||
| Industry Sales Growth Rate | 4.0% | 13.6 | ||
| Industry Net Profit Margin | 19.3% | 18.3 | ||
| Calculated Quality Rating | 79.9 | |||
| Fool CAPS | ||||
Total Players
13610
Outperforms
514
Underperforms
All-Stars (2737)
2685
Outperforms (98%)
52
Underperforms
|
||||
| Fundamental Data Updated: 11/11/2022 | ||||